Characterization of FR173657, a novel nonpeptide B2 antagonist: In vitro and in vivo studies

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 6, 1997, Pages 622-628

  Inamura, Noriaki ^a   Asano, Masayuki ^a   Kayakiri, Hiroshi ^a   Hatori, Chie ^a   Oku, Teruo ^a   Nakahara, Kunio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Antagonist; Bradykinin; Nonpeptide; Oral treatment

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; BRONCHOSPASM; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; GUINEA PIG; HUMAN; HUMAN CELL; ILEUM; IN VITRO STUDY; LUNG; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION;

ADMINISTRATION, ORAL; ANIMALS; BRADYKININ; BRONCHOCONSTRICTION; CELLS, CULTURED; DRUG INTERACTIONS; GUINEA PIGS; HUMANS; ILEUM; LUNG; MALE; MEMBRANES; MUSCLE CONTRACTION; QUINOLINES; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; TRITIUM;

EID: 0030715723     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-75-6-622     Document Type: Conference Paper

References (29)

1. Asano, M., Inamura, N., Nakahara, K., Nagayoshi, A., Isono, T., Hamada, K., Oku, T., Notsu, Y., Kohsaka, M., and Ono, T. 1992. A 5-lipoxygenase inhibitor, FR110302, suppresses airway hyperresponsiveness and lung eosinophilia induced by sephadex particles in rats. Agents Actions, 36: 215-221.
2. 2 bradykinin receptors with nanomolar affinity expressed in passaged IMR90 human lung fibroblasts. Eur. J. Cell Biol. 58: 71-80.
3. Bhoola, K.D., Figueroa, C.D., and Worthy, K. 1992. Bioregulatin of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44: 1-80.
4. 50) of an enzyme reaction. Biochem. Pharmacol. 22: 3099-3108.
5. Cheronis, J.C., Whalley, E.T., Nguyen, K.T., Eubanks, S.R., Allen, L.G., Duggan, M.J., Loy, S.D., Bonham, K.A., and Blodgett, J.K. 1992. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers. J. Med. Chem. 35: 1563-1572.
6. Christiansen, S.C., Proud, D., and Cochrane, C.G. 1987. Detection of tissue kallikrein in bronchoalveolar lavage fluid of asthmatic subjects. J. Clin. Invest. 79: 188-197.
7. Farmer, S.G. 1991. Role of kinins in airway diseases. Immunopharmacology, 22: 1-20.
8. 3 receptor. Br. J. Pharmacol. 112: 461-464.
9. 2 receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther. 273: 1071-1077.
10. Fuller, R.W., Dixon, C.M., Cuss, F.M., and Barnes, P.J. 1987. Bradykinin-induced bronchoconstriclion in humans. Mode of action. Am. Rev. Respir. Dis. 135: 176-180.
11. Gobeil, F., Pheng, L.H., Badini, L, Nguyen-Le, X.K., Pizard, A., Rizzi, A., Blouin, D., and Regoli, D. 1996. Receptors for kinins in the human isolated umbilical vein. Br. J. Pharmacol. 118: 289-294.
12. Griesbacher, T., Lembeck, F., and Saria, A. 1989. Effect of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation. Br. J. Pharmacol. 96: 531-538.
13. 2 bradykinin receptors. Mol. Pharmacol. 45: 1-8.
14. Hock, F.J., Wirth, K., Albus, U., Linz, W., Gerhards, H.J., Wiemer, G., Breipohl, G., Konig, W., Knolle, J., and Scholkens, B.A. 1991. Hoe140, a new, potent and long-acting bradykinin antagonist: in vitro studies. Br. J. Pharmacol. 102: 769-773.
15. 2 receptors isolated by receptor-specific monoclonal antibodies are tyrosine phosphorylated. Proc. Natl. Acad. Sci. U.S.A. 90: 10 994-10 998.
16. Kluft, C. 1978. Determination of prekallikrein in human plasma - optimal conditions for activating prekallikrein. J. Lab. Clin. Med. 91:83-95.
17. Kyle, D.J., Martin, J.A., Farmer, S.G., and Burch, R.M. 1991. Design and conformation analysis of several highly potent bradykinin receptor antagonists. J. Med. Chem. 34: 1230-1233.
18. Lembeck, F., Griesbacher, T., Eckhardt, M., Henke, S., Breipohl, G., and Knolle, J. 1991. New, long active, potent bradykinin antagonists. Br. J. Pharmacol. 102: 297-304.
19. Manning, D.C., Vavrek, R., Stewart, J.M., and Snyder, S.H. 1986. Two bradykinin binding sites with picomolar affinities. J. Pharmacol. Exp. Then 237: 504-512.
20. 1 bradykinin receptor. J. Biol. Chem. 269: 21 583-21 586.
21. Morimoto, H., Yamashita, M., Matsuda, A., Ohori, M., Miyake, H., and Fujii, T. 1996. Characterization of dextran sulfate-induced guinea pig tracheal plasma extravasatiion. Jpn. J. Pharmacol. 72: 217-221.
22. Proud, D., and Kaplan, A.P. 1988. Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol. 6: 49-83.
23. Regoli, D., Barabe, J., and Park, W.K. 1977. Receptors for bradykinin in rabbit aortae. Can. J. Physiol. Pharmacol. 55: 855-867.
24. Roberts, R.A., and Gullick, W.J. 1989. Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis is increased by expression of a mutant ras oncogene. J. Cell Sci. 94: 527-535.
25. 2 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A. 91: 4693-4697.
26. Sawutz, D.G., Salvino, J.M., Dolle, R.E., Seoane, P.R., and Farmer, S.G. 1995. Pharmacology and structure-activity relationships of the nonpeptide bradykinin receptor antagonist WIN 64338. Can. J. Physiol. Pharmacol. 73: 805-811.
27. Takakura, S., Satoh, Y., Satoh, H., Mori, J., and Kohsaka, M. 1992. Effect of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats. Arch. Int. Pharmacodyn. Ther. 319: 38-18.
28. Vavrek, R.J., and Stewart, J.M. 1985. Competitive antagonists of bradykinin. Peptides (Elmsford), 6: 161-164.
29. Wirth, K., Hock, F.J., Albus, U., Linz, W., Alpermann, H.G., Anagnostopoulos, H., Henke, S., Breipohl, G., Konig, W., Knolle, J., and Scholkens, B.A. 1991. Hoe 140, a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol. 102: 774-777.